fluorexon has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, S; Chen, MH; Izawa, K; Kobayashi, S; Maruyama, K; Soda, Y; Tani, K; Tojo, A | 1 |
| Fukuda, M; Kawabata, S; Kohno, S; Nakamura, T; Nakatomi, K; Noguchi, Y; Oka, M; Shiozawa, K; Soda, H; Suenaga, M; Tei, C; Terashi, K; Tsukamoto, K | 1 |
2 other study(ies) available for fluorexon and Leukemia
| Article | Year |
|---|---|
A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD7; Biological Transport; Biotinylation; Cell Survival; Chemistry, Pharmaceutical; Cytarabine; Dose-Response Relationship, Drug; Female; Fluoresceins; Fluorescent Dyes; Granulocyte Colony-Stimulating Factor; Humans; Inhibitory Concentration 50; Jurkat Cells; K562 Cells; Leukemia; Lipids; Liposomes; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Receptors, Granulocyte Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3; Streptavidin; Technology, Pharmaceutical; Xenograft Model Antitumor Assays | 2013 |
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Interactions; Erythromycin; Fluoresceins; Genes, MDR; Humans; Leukemia; Ofloxacin; Tumor Cells, Cultured; Vincristine | 2000 |